Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Kyowa Hakko Kirin Pharma)"
Count: 22
Selected: 0
NCT IDTitle
NCT01447732Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors
NCT02610231Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
NCT02609477A Study to Evaluate Abuse Potential of Istradefylline
NCT01968031A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
NCT01571596An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
NCT01340482A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia
NCT01063907A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma
NCT02256033Effect of Mild Hepatic Impairment on the Pharmacokinetics of Istradefylline
NCT02174250The Effect of Rifampin on the Metabolism of Istradefylline in Healthy Volunteers.
NCT02127476A Study of Single and Multiple Doses of KHK6640 in Subjects With Prodromal or Mild to Moderate Alzheimer's Disease
NCT01611142Study of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL)
NCT01279291Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
NCT01226472Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001
NCT01199367Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer
NCT00921336Safety Study to Evaluate KW-2450 in Subjects With Advanced Solid Tumor
NCT00888927Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma
NCT00838578Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
NCT00830674A Study of KRN23 in X-linked Hypophosphatemia
NCT00779480Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of KW-2449 in Acute Myelogenous Leukemia (AML) (Protocol Number: 2449-US-002)
NCT00775502Phase 1/2 Study of Anti GM-2 Monoclonal Antibody To Treat Multiple Myeloma
NCT02281409Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid Tumors
NCT00952094Pharmacokinetic, Pharmacodynamic and Safety Evaluation After Single Oral Administration of KRN1493